```html

Bilateral Vestibular Neuritis

Overview

Bilateral vestibular neuritis (BVN) is an acute or sub‑acute inflammation of the vestibular branch of the eighth cranial nerve (the vestibulocochlear nerve) affecting **both ears**. The condition impairs the brain’s ability to receive balance information from the inner ears, leading to severe vertigo, disequilibrium, and visual disturbances.

BVN is much rarer than the more common unilateral vestibular neuritis. While unilateral vestibular neuritis occurs in ~3.5–5 per 100,000 adults per year, bilateral involvement is estimated at 0.5–1 % of those cases, translating to roughly 0.02–0.05 per 100,000 people annually [Mayo Clinic, 2023]. It can affect anyone, but the median age of onset is 45–55 years, and there is a slight male predominance.

Symptoms

The hallmark of BVN is the simultaneous loss of vestibular function on both sides, producing a constellation of symptoms that may develop over hours to days. Common features include:

Vertigo & Dizziness

• Spontaneous vertigo: A sensation that the room is spinning, often described as “room‑tilt” or “rocking.”
• Non‑positional: Unlike benign paroxysmal positional vertigo (BPPV), the vertigo does not change with head position.

Balance Problems

• Unsteady gait, tendency to fall sideways or backward.
• Difficulty walking on uneven surfaces or in low‑light conditions.

Oscillopsia

• Blurred or “jumping” vision during head movements because the brain cannot stabilize images.

Nausea & Vomiting

• Often severe during the first 24–48 hours.

Auditory Symptoms (less common)

• Mild hearing loss or tinnitus may occur if the cochlear branch is partially involved, but true hearing loss usually points to a different diagnosis (e.g., labyrinthitis).

Autonomic Changes

• Diaphoresis, palpitations, or a feeling of “panic” triggered by the overwhelming dizziness.

Fatigue & Concentration Difficulty

• Persistent vestibular fatigue can lead to “brain fog” and reduced ability to focus.

Symptoms typically peak within the first 48 hours and can gradually improve over weeks to months, but some patients experience lingering imbalance or oscillopsia lasting >6 months.

Causes and Risk Factors

The exact cause of BVN remains uncertain, but several mechanisms are widely accepted:

Viral Infection

• Reactivation of latent herpes simplex virus type 1 (HSV‑1) or varicella‑zoster virus (VZV) within the vestibular nerve is the leading hypothesis [NIH, 2022].
• Recent upper‑respiratory or gastrointestinal illness is reported in 30‑40 % of cases.

Immune‑Mediated Inflammation

• Cross‑reactivity between viral antigens and vestibular nerve proteins may trigger an autoimmune attack.

Vascular Insult

• Microvascular ischemia of the vestibular artery can produce a similar picture, especially in patients with hypertension or diabetes.

Trauma

• Rarely, temporal bone fracture or severe head acceleration‑deceleration can damage both vestibular nerves simultaneously.

Risk Factors

• Age > 40 years – age‑related vascular and immune changes increase susceptibility.
• Male sex – modestly higher incidence.
• Recent viral illness – especially influenza, COVID‑19, or herpes infections.
• Immunosuppression – organ transplant, chemotherapy, HIV.
• Cardiovascular risk factors – hypertension, diabetes, hyperlipidemia.

Diagnosis

Because BVN mimics other causes of acute imbalance, a systematic approach is essential.

Clinical History & Physical Exam

• Sudden, bilateral vertigo without a clear trigger.
• Absence of hearing loss (helps separate from labyrinthitis or sudden sensorineural hearing loss).
• Positive head‑impulse test (HIT) bilaterally – reduced vestibulo‑ocular reflex (VOR) gain.
• Emphasis on gait instability and oscillopsia.

Bedside Vestibular Tests

• Head‑Impulse Test (HIT) – rapid, small‑amplitude head turns; corrective saccades indicate vestibular hypofunction.
• Dix‑Hallpike maneuver – typically negative (rules out BPPV).
• Romberg & Tandem walking – increased sway with eyes closed.

Instrumental Testing

Test	Purpose	Typical Finding in BVN
Video‑Head‑Impulse Test (vHIT)	Quantifies VOR gain.	Reduced gain (<0.7) on both sides.
Caloric Testing	Assesses low‑frequency vestibular response.	Symmetrical hyporeflexia (both ears).
Rotational Chair	Measures VOR across a range of speeds.	Broadly diminished responses.
Vestibular‑Evoked Myogenic Potentials (VEMPs)	Tests otolith organ function.	Absent or reduced amplitudes bilaterally.
MRI with gadolinium	Excludes central lesions (stroke, tumor).	Usually normal; may show contrast enhancement of the vestibular nerves if inflamed.

Laboratory Work‑up (selected cases)

• Complete blood count, CRP/ESR – to detect systemic inflammation.
• Serology for HSV‑1, VZV, COVID‑19 – if a viral etiology is suspected.
• Autoimmune panel (ANA, ENA) if there is a broader neurologic picture.

Diagnosis is made when bilateral vestibular hypofunction is documented, other causes (stroke, demyelination, Ménière disease) are excluded, and the clinical picture fits the typical acute onset.

Treatment Options

Therapeutic goals are to reduce acute symptoms, control inflammation, prevent long‑term disability, and promote vestibular compensation.

Acute Symptom Control

• Vestibular suppressants – Meclizine 25‑50 mg PO q6‑8 h, or antihistamines (diphenhydramine). Use only for the first 24–48 h; prolonged use can delay compensation.
• Antiemetics – Ondansetron 4‑8 mg IV/PO q8 h for severe nausea.
• Analgesics – NSAIDs (ibuprofen 400‑600 mg q6‑8 h) for headache or neck pain.

Anti‑Inflammatory / Antiviral Therapy

• Corticosteroids – Prednisone 1 mg/kg/day (max 60 mg) for 5‑7 days, then taper over 1 week. Evidence from a 2021 randomized trial shows modest improvement in VOR gain recovery [Cleveland Clinic, 2021].
• Antivirals (in selected cases) – Acyclovir 800 mg PO q5 h for 7 days if HSV reactivation is strongly suspected (e.g., prodromal vesicular rash).

Vestibular Rehabilitation Therapy (VRT)

Early referral to a physical therapist trained in VRT is the cornerstone of long‑term recovery. Programs typically include:

• Gaze stabilization exercises (X‑1, X‑2).
• Balance training on compliant surfaces.
• Habituation exercises for motion‑induced dizziness.
• Progressive functional tasks (e.g., walking while turning the head).

Most patients report measurable improvement within 4‑6 weeks [American Physical Therapy Association, 2022].

Adjunctive Measures

• Hydration & electrolytes – Prevent orthostatic hypotension.
• Sleep hygiene – Adequate rest aids neural plasticity.
• Avoid alcohol & sedatives – These can exacerbate vestibular dysfunction.

Surgical / Interventional Options

There is no surgical cure for BVN. In refractory cases where vertigo persists despite optimal rehab, some centers consider a vestibular nerve section on the less functional side, but this is rare and reserved for debilitating unilateral cases, not bilateral disease.

Living with Bilateral Vestibular Neuritis

Managing everyday life after BVN focuses on safety, gradual activity, and ongoing vestibular rehab.

Home Safety

• Install grab bars in the bathroom and non‑slip mats.
• Use nightlights to reduce disorientation in dark rooms.
• Keep pathways clear of clutter and rugs.

Work & Mobility

• Consider a gradual return‑to‑work plan; start with seated duties.
• If driving, wait until you can pass a formal vestibular assessment (usually 4–6 weeks after symptom onset).
• Use mobility aids (cane or walker) until balance improves.

Exercise & Activity

• Begin with seated or supine VRT exercises; progress to standing as tolerated.
• Low‑impact activities such as stationary cycling or swimming are well tolerated.
• Avoid rapid head turns, roller‑coasters, or high‑speed sports until cleared.

Nutrition & Lifestyle

• Maintain a balanced diet rich in omega‑3 fatty acids (fish, flaxseed) which may support neural recovery.
• Stay well‑hydrated; dehydration worsens orthostatic dizziness.
• Limit caffeine and alcohol, both of which can destabilize vestibular compensation.

Psychological Support

Persistent dizziness can lead to anxiety or depression. Referral to a mental‑health professional, mindfulness training, or support groups is recommended.

Prevention

Because BVN is often triggered by viral reactivation, absolute prevention is difficult, but risk can be mitigated:

• Stay up‑to‑date with vaccinations (influenza, COVID‑19, shingles).
• Manage chronic illnesses (blood pressure, diabetes) to preserve microvascular health.
• Adopt good hand‑hygiene and avoid close contact with people who have active respiratory infections.
• Limit stress; chronic stress may impair immune regulation and promote viral reactivation.
• Consider prophylactic antiviral therapy only in rare immunosuppressed patients under specialist guidance.

Complications

If vestibular loss remains uncompensated, several complications can arise:

• Chronic imbalance – increased risk of falls and related injuries, especially in older adults.
• Oscillopsia – persistent visual blurring with head movement, interfering with driving or reading.
• Psychological distress – anxiety, panic disorder, or depression.
• Reduced quality of life – limitations in work, social activities, and recreation.
• Secondary vestibular migraine – some patients develop migrainous vertigo after the acute episode.

When to Seek Emergency Care

Early evaluation reduces the risk of misdiagnosis and ensures prompt treatment.

---

References: Mayo Clinic. Vestibular neuritis. 2023; NIH. Viral causes of vestibular disorders. 2022; Cleveland Clinic. Corticosteroids in vestibular neuritis: randomized trial. 2021; American Physical Therapy Association. Vestibular Rehabilitation Clinical Guidelines. 2022; World Health Organization. Prevention of viral infections. 2024.

```